These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33432334)

  • 1. Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies.
    Cirrincione LR; Narla RR
    J Appl Lab Med; 2021 Jan; 6(1):219-235. PubMed ID: 33432334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone health in transgender assigned female at birth people: effects of gender-affirming hormone therapy and gonadectomy.
    Sanna E; Lami A; Giacomelli G; Alvisi S; Paccapelo A; Seracchioli R; Meriggiola MC
    Front Endocrinol (Lausanne); 2024; 15():1416121. PubMed ID: 39391880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.
    Nolan BJ; Cheung AS
    Intern Med J; 2024 Sep; 54(9):1450-1457. PubMed ID: 39056542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults.
    Cirrincione LR; Winston McPherson G; Rongitsch J; Sadilkova K; Drees JC; Krasowski MD; Dickerson JA; Greene DN
    LGBT Health; 2021; 8(2):125-132. PubMed ID: 33439749
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen.
    Scheres LJJ; Selier NLD; Nota NM; van Diemen JJK; Cannegieter SC; den Heijer M
    J Thromb Haemost; 2021 Apr; 19(4):1029-1037. PubMed ID: 33527671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial.
    Cortez S; Moog D; Lewis C; Williams K; Herrick C; Fields M; Gray T; Guo Z; Nicol G; Baranski T
    JMIR Res Protoc; 2023 Dec; 12():e53092. PubMed ID: 38133914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Gender-Affirming Hormone Therapy on Serum Creatinine in Transgender Individuals.
    Maheshwari A; Dines V; Saul D; Nippoldt T; Kattah A; Davidge-Pitts C
    Endocr Pract; 2022 Jan; 28(1):52-57. PubMed ID: 34474185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis and Bone Health in Transgender Individuals.
    Verroken C; Collet S; Lapauw B; T'Sjoen G
    Calcif Tissue Int; 2022 May; 110(5):615-623. PubMed ID: 35366693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterising body composition and bone health in transgender individuals receiving gender-affirming hormone therapy.
    Ford K; Huggins E; Sheean P
    J Hum Nutr Diet; 2022 Dec; 35(6):1105-1114. PubMed ID: 35509260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
    Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
    Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
    Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough Bleeding in Transgender and Gender Diverse Adolescents and Young Adults on Long-Term Testosterone.
    Grimstad F; Kremen J; Shim J; Charlton BM; Boskey ER
    J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):706-716. PubMed ID: 33910088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
    Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
    Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
    Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.